Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13615784 | 1.00 | HPGD (0.41) | HPGDADRA2AADRA2BADRA2C | |
| SCHEMBL13615971 | 0.90 | ADRA2A (0.36) | HPGDADRA2AADRA2BADRA2C | |
| SCHEMBL13615787 | 0.90 | ADRA2A (0.36) | HPGDADRA2AADRA2BADRA2C | |
| SCHEMBL13615830 | 0.81 | — | — | |
| SCHEMBL13426904 | 0.80 | HPGD (0.41) | HPGDADRA2AADRA2BADRA2C | |
| SCHEMBL22548637 | 0.80 | HPGD (0.38) | HPGDADRA2AADRA2BADRA2C | |
| SCHEMBL13508192 | 0.79 | HPGD (0.36) | HPGD | |
| SCHEMBL13507856 | 0.79 | HPGD (0.36) | HPGD | |
| SCHEMBL13339215 | 0.79 | HPGD (0.34) | HPGD | |
| SCHEMBL13507253 | 0.78 | HPGD (0.37) | HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | HPGD 1011/4885ADRA2A 3086/4885ADRA2B 2936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.